T&R Biofab Co., Ltd. (KOSDAQ: 246710)

Market Cap	86.73B
Revenue (ttm)	5.08B
Net Income (ttm)	-13.74B
Shares Out	21.55M
EPS (ttm)	-640.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	177,783
Average Volume	119,057
Open	4,150.00
Previous Close	4,075.00
Day's Range	4,075.00 - 4,480.00
52-Week Range	3,420.00 - 9,890.00
Beta	0.82
RSI	37.80
Earnings Date	Mar 17, 2025

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 246710

Financial Performance

In 2023, T&R Biofab's revenue was 5.20 billion, a decrease of -9.65% compared to the previous year's 5.75 billion. Losses were -13.42 billion, 29.8% more than in 2022.